To evaluate this, we used shRNAs to derive PU.1-deficient B-ALL cells, which displayed normal proliferation and viability (Figure 3—figure supplement 3, data not shown). This evidence concerns the gene SPI1 and precursor B-cell acute lymphoblastic leukemia.